Jonatan D. Lindh - Concepedia

Author

Jonatan D. Lindh

Also Known As

J D Lindh, J LINDH, J Lindh, J. D. Lindh, J. Lindh, J.D. Lindh, Jonatan D. Lindh, Jonatan D Lindh, Jonatan D. Lindh, Jonatan Lindh

127

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Stockholm South General Hospital Karlstad Central Hospital Uppsala University Hospital

About

Jonatan D. Lindh is an author at Karolinska Institutet specializing in medicine, pharmacotherapy, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.2K
2	Public Health	7	7	874
3	Social Sciences	2	2	73
4	Health Sciences	1	1	26
5	Biochemistry	1	1	21

Jonatan D. Lindh

Publications

Citations

H-Index

Page 1

	Year	Citations
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose Fumihiko Takeuchi, Ralph McGinnis, Stéphane Bourgeois, PLoS Genetics Genome-wide Association StudyThrombosisTherapeutic Warfarin DoseMedicineGenetics	2009	635
The largest prospective warfarin-treated cohort supports genetic forecasting Mia Wadelius, Leslie Y. Chen, Jonatan D. Lindh, Blood	2008	551
Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing Petra Lenzini, Mia Wadelius, Stephen Kimmel, Clinical Pharmacology & Therapeutics	2010	214
Vitamin D<sub>3</sub> supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study Peter Bergman, Anna-Carin Norlin, Susanne Hansen, BMJ Open	2012	187
A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age Anna‐Karin Hamberg, Mia Wadelius, Jonatan D. Lindh, Clinical Pharmacology & Therapeutics	2010	96
Incidence and predictors of severe bleeding during warfarin treatment Jonatan D. Lindh, Lennart Holm, Marja‐Liisa Dahl, Journal of Thrombosis and Thrombolysis ThrombosisCardiovascular DiseaseMedicineClinical EpidemiologyHematology	2007	75
Several-fold increase in risk of overanticoagulation by CYP2C9 mutations Jonatan D. Lindh, Stefan Lundgren, Lotte Holm, Clinical Pharmacology & Therapeutics	2005	74
Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia Shermineh Farmand, Jonatan D. Lindh, Jan Calissendorff, The American Journal of Medicine Hospitalization DuePsychiatryPsychotropic MedicationDepressionSepsis	2017	74
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy Petra Lenzini, Mia Wadelius, Andrea Jorgensen, Thrombosis and Haemostasis	2011	70
Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care Marine L. Andersson, Ylva Böttiger, Jonatan D. Lindh, European Journal of Clinical Pharmacology Drug InteractionsSubstance AbusePrimary CareSerious Drug-drug InteractionsHealth Policy	2012	63

Page 1